Download PDF
MSK – Muskuloskelettale Physiotherapie 2023; 27(05): 251-257
DOI: 10.1055/a-2140-6155
Schwerpunkt | Einführung

Die Kraft der Erwartung nutzen

Ulrike Bingel
› Further Information
Also available at
    Permissions and Reprints

Placebo-Effekte fördern und Nocebo-Effekte vermeiden – das ist bei nahezu jeder Behandlung sinnvoll und möglich. Jeder Eingriff, jede Medikamenteneinnahme, Neurostimulation oder Physiotherapie unterliegt auch einem Erwartungseffekt. Für Therapeut*innen ist wichtig zu wissen, wie sie durch authentische und empathische Kommunikation ihre Patient*innen unterstützen können. Am Beispiel der Placeboanalgesie lassen sich Effekte, Mechanismen und kommunikative Aspekte besonders gut zeigen.



Publication History

Article published online:
14 December 2023

© 2023. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • Literatur

  • 1 . Bingel U. Placebo Competence Team. Avoiding nocebo effects to optimize treatment outcome. JAMA 2014; 312: 693-694
    CrossrefPubMedSearch in Google Scholar
  • 2 Schedlowski M, Enck P, Rief W. et al. Neuro-Bio-Behavioral Mechanisms of Placebo and Nocebo Responses: Implications for Clinical Trials and Clinical Practice. Pharmacol Rev 2015; 67: 697-730
    CrossrefPubMedSearch in Google Scholar
  • 3 Petrie KJ, Rief W. Psychobiological mechan- isms of placebo and nocebo effects: pathways to improve treatments and reduce side effects. Annu Rev Psychol 2019; 70: 599-625
    CrossrefPubMedSearch in Google Scholar
  • 4 Scott DJ, Stohler CS, Egnatuk CM. et al. Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses. Arch Gen Psychiatry 2008; 65: 220-231
    CrossrefPubMedSearch in Google Scholar
  • 5 Vlemincx E, Sprenger C, Büchel C. Expectation and dyspnea: The neurobiological basis of respiratory nocebo effects. Eur Respir J 2021; 58: 2003008
    CrossrefPubMedSearch in Google Scholar
  • 6 Bingel U, Wanigasekera V, Wiech K. et al The effect of treatment expectation on drug efficacy: imaging the analgesic benefit of the opioid remifentanil. Sci Transl Med 2011; 3 70ra14.7
    CrossrefPubMedSearch in Google Scholar
  • 7 Stuhlreyer J, Schwartz M, Friedheim T. et al. Optimising treatment expectations in chronic lower back pain through observing others: a study protocol for a randomised clinical trial. BMJ Open 2022; 12: e059044
    CrossrefPubMedSearch in Google Scholar
  • 8 Benson S, Hagen S, Hoffmann O. et al. Can a brief psychological expectancy intervention improve postoperative pain? A randomized, controlled trial in patients with breast cancer. PAIN 2019; 160: 1562-1571
    CrossrefPubMedSearch in Google Scholar
  • 9 Kaptchuk TJ, Kelley JM, Conboy LA. et al. Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome. BMJ 2008; 336: 999-1003
    CrossrefPubMedSearch in Google Scholar
  • 10 van Lennep JHPA, Trossel F, Perez RSGM. et al. Placebo effects in low back pain: A systematic review and meta-analysis of the literature. Eur J Pain 2021; 25: 1867-1897
    CrossrefPubMedSearch in Google Scholar
  • 11 Maser D, Müller D, Bingel U. et al. Ergebnisse einer Pilotstudie zur Rolle der Therapieerwartung bei der interdisziplinären multimodalen Schmerztherapie bei chronischem Rückenschmerz. [Results of a pilot study on the role of therapy expectation in interdisciplinary multimodal pain therapy for chronic back pain.] Schmerz 2022; 36: 172-181
    CrossrefPubMedSearch in Google Scholar
  • 12 Kam-Hansen S, Jakubowski M, Kelley JM. et al. Altered placebo and drug labeling changes the outcome of episodic migraine attacks. Sci Transl Med 2014; 6: 218ra5
    CrossrefPubMedSearch in Google Scholar
  • 13 Schmidt K, Berding T, Kleine-Borgmann J. et al. The beneficial effect of positive treatment expectations on pharmacological migraine prophylaxis. Pain 2022; 163: e319-e327
    CrossrefPubMedSearch in Google Scholar
  • 14 Wager TD, Rilling JK, Smith EE. et al. Placebo-induced changes in FMRI in the anticipation and experience of pain. Science 2004; 303: 1162-1167
    CrossrefPubMedSearch in Google Scholar
  • 15 Bingel U, Lorenz J, Schoell E. et al. Mechanisms of placebo analgesia: rACC recruitment of a subcortical antinociceptive network. Pain 2006; 120: 8-15
    CrossrefPubMedSearch in Google Scholar
  • 16 Eippert F, Bingel U, Schoell ED. et al. Activation of the opioidergic descending pain control system underlies placebo analgesia. Neuron 2009; 63: 533-543
    CrossrefPubMedSearch in Google Scholar
  • 17 Eippert F, Finsterbusch J, Bingel U. et al. Direct evidence for spinal cord involvement in placebo analgesia. Science 2009; 326: 404
    CrossrefPubMedSearch in Google Scholar
  • 18 Asan L, Bingel U, Kunkel A. Neurobiologische und neurochemische Mechanismen der Placeboanalgesie. [Neurobiological and neurochemical mechanisms of placebo analgesia.] Schmerz 2022; 36: 205-212
    CrossrefPubMedSearch in Google Scholar
  • 19 Levine JD, Gordon NC, Fields HL. The mechanism of placebo analgesia. Lancet 1978; 2: 654-657
    CrossrefPubMedSearch in Google Scholar
  • 20 Benedetti F, Pollo A, Colloca L. Opioid-me-diated placebo responses boost pain endurance and physical performance: is it doping in sport competitions?. J Neurosci 2007; 27: 11934-11939
    CrossrefPubMedSearch in Google Scholar
  • 21 Petrovic P, Kalso E, Petersson KM. et al. Placebo and opioid analgesia—imaging a shared neuronal network. Science 2002; 295: 1737-1740
    CrossrefPubMedSearch in Google Scholar
  • 22 Wager TD, Atlas LY. The neuroscience of placebo effects: connecting context, learning and health. Nat Rev Neurosci 2015; 16: 403-418
    CrossrefPubMedSearch in Google Scholar
  • 23 Lidstone SC, de la Fuente-Fernandez R, Stoessl AJ. The placebo response as a reward mechanism. Seminars Pain Med 2005; 3: 37-42
    CrossrefSearch in Google Scholar
  • 24 Eisenegger C, Naef M, Linssen A. et al. Role of dopamine D2 receptors in human reinforcement learning. Neuropsychopharmacology 2014; 39: 2366-2375
    CrossrefPubMedSearch in Google Scholar